Verily Secures Strategic Investment from NVIDIA to Accelerate Precision Health AI Platform9. September 2026
News Avulux Earns FDA Clearance, Establishing First Device Classification for Migraine Light SensitivityHealthradar27. August 2026 What You Should Know The U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization to Avulux, establishing…
Gadgets Brightstar Capital Partners Acquires Analyte Health, Establishing Platform in Direct-to-Consumer HealthcareHealthradar12. August 2025 Analyte Founder Fiyyaz Pirani to Continue as CEO and Retain Significant Ownership Stake NEW YORK & HOUSTON–(BUSINESS WIRE)–Brightstar Capital Partners…
